Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Health Care

63.27
+0.01250.02%
Post-market: 63.270.00000.00%16:10 EDT
Volume:17.10K
Turnover:1.08M
Market Cap:96.80M
PE:- -
High:63.50
Open:63.50
Low:62.25
Close:63.26
52wk High:64.60
52wk Low:39.32
Shares:1.53M
Float Shares:1.53M
Volume Ratio:1.31
T/O Rate:1.12%
Dividend:0.71
Dividend Rate:1.12%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

Lytix Biopharma Names Timothy Herpin Chief Business Officer

Reuters
·
Aug 18

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Reuters
·
Aug 18

Perrigo Co. PLC Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Luigi Mangione's State Murder Trial is Postponed After Federal Guilty Plea

Reuters
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Update: Luigi Mangione Reportedly to Plead Guilty Over Former UnitedHealth Executive Killing, Lawyer Says

MT Newswires Live
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

J&J Receives U.S. FDA 510(k) Clearance for Monarch Quest 3

Reuters
·
Aug 17

Johnson & Johnson Announces Monarch™ Quest 3, Advancing the Latest in Robotically-Assisted Bronchoscopy

THOMSON REUTERS
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

Merck upgraded to Outperform from Neutral at Daiwa

TIPRANKS
·
Aug 17